Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 304

1.

Factor Analysis and Clustering of the Movement Disorder Society-Non-Motor Rating Scale.

Martinez-Martin P, Rojo-Abuín JM, Weintraub D, Chaudhuri KR, Rodriguez-Blázquez C, Rizos A, Schrag A.

Mov Disord. 2020 Mar 27. doi: 10.1002/mds.28002. [Epub ahead of print]

PMID:
32220114
2.

Drooling in Parkinson's Disease: Prevalence and Progression from the Non-motor International Longitudinal Study.

van Wamelen DJ, Leta V, Johnson J, Ocampo CL, Podlewska AM, Rukavina K, Rizos A, Martinez-Martin P, Chaudhuri KR.

Dysphagia. 2020 Mar 4. doi: 10.1007/s00455-020-10102-5. [Epub ahead of print]

PMID:
32130515
3.

Genome-Wide Association Study of Pain in Parkinson's Disease Implicates TRPM8 as a Risk Factor.

Williams NM, Hubbard L, Sandor C, Webber C, Hendry H, Lawton M, Carroll C, Chaudhuri KR, Morris H, Hu MT, Grosset DG, Kobylecki C, Silverdale M; UK Parkinson's Pain Study.

Mov Disord. 2020 Feb 20. doi: 10.1002/mds.28001. [Epub ahead of print] No abstract available.

PMID:
32078185
4.

Keep calm and beam on? Unmet needs in radiotherapy and deep brain stimulation.

Smilowska K, Bloem BR, Esselink RAJ, Chaudhuri KR, van Wamelen DJ.

Parkinsonism Relat Disord. 2020 Feb;71:15-16. doi: 10.1016/j.parkreldis.2020.01.005. Epub 2020 Jan 11. No abstract available.

PMID:
31955127
5.

Dementia in long-term Parkinson's disease patients: a multicentre retrospective study.

Szeto JYY, Walton CC, Rizos A, Martinez-Martin P, Halliday GM, Naismith SL, Chaudhuri KR, Lewis SJG.

NPJ Parkinsons Dis. 2020 Jan 7;6:2. doi: 10.1038/s41531-019-0106-4. eCollection 2020.

6.

Potential of animal models for advancing the understanding and treatment of pain in Parkinson's disease.

Buhidma Y, Rukavina K, Chaudhuri KR, Duty S.

NPJ Parkinsons Dis. 2020 Jan 6;6:1. doi: 10.1038/s41531-019-0104-6. eCollection 2020. Review.

7.

Detecting Parkinsonian Tremor from IMU Data Collected In-The-Wild using Deep Multiple-Instance Learning.

Papadopoulos A, Kyritsis K, Klingelhoefer L, Bostanjopoulou S, Chaudhuri KR, Delopoulos A.

IEEE J Biomed Health Inform. 2019 Dec 24. doi: 10.1109/JBHI.2019.2961748. [Epub ahead of print]

PMID:
31880570
8.

Reply to: "Parkinson disease-associated dyskinesia in countries with low access to levodopa-sparing Regimens".

Chaudhuri KR, Jenner P, Antonini A.

Mov Disord. 2019 Dec;34(12):1930-1931. doi: 10.1002/mds.27871. No abstract available.

PMID:
31845760
9.

Applications of the European Parkinson's Disease Association sponsored Parkinson's Disease Composite Scale (PDCS).

Balestrino R, Hurtado-Gonzalez CA, Stocchi F, Radicati FG, Chaudhuri KR, Rodriguez-Blazquez C, Martinez-Martin P; PDCS European Study Group.

NPJ Parkinsons Dis. 2019 Nov 27;5:26. doi: 10.1038/s41531-019-0097-1. eCollection 2019.

10.

Acupuncture Effect and Mechanism for Treating Pain in Patients With Parkinson's Disease.

Yu SW, Lin SH, Tsai CC, Chaudhuri KR, Huang YC, Chen YS, Yeh BY, Wu YR, Wang JJ.

Front Neurol. 2019 Oct 22;10:1114. doi: 10.3389/fneur.2019.01114. eCollection 2019.

11.

Sleep disturbances and gastrointestinal dysfunction are associated with thalamic atrophy in Parkinson's disease.

Niccolini F, Wilson H, Giordano B, Diamantopoulos K, Pagano G, Chaudhuri KR, Politis M.

BMC Neurosci. 2019 Oct 22;20(1):55. doi: 10.1186/s12868-019-0537-1.

12.

Can therapeutic strategies prevent and manage dyskinesia in Parkinson's disease? An update.

Leta V, Jenner P, Chaudhuri KR, Antonini A.

Expert Opin Drug Saf. 2019 Dec;18(12):1203-1218. doi: 10.1080/14740338.2019.1681966. Epub 2019 Nov 5. Review.

PMID:
31619083
13.

Non-motor correlates of wrist-worn wearable sensor use in Parkinson's disease: an exploratory analysis.

van Wamelen DJ, Hota S, Podlewska A, Leta V, Trivedi D, Rizos A, Parry M, Chaudhuri KR.

NPJ Parkinsons Dis. 2019 Oct 2;5:22. doi: 10.1038/s41531-019-0094-4. eCollection 2019.

14.

The movement disorder society nonmotor rating scale: Initial validation study.

Chaudhuri KR, Schrag A, Weintraub D, Rizos A, Rodriguez-Blazquez C, Mamikonyan E, Martinez-Martin P.

Mov Disord. 2020 Jan;35(1):116-133. doi: 10.1002/mds.27862. Epub 2019 Sep 30.

PMID:
31571279
15.

Validation of a self-completed Dystonia Non-Motor Symptoms Questionnaire.

Klingelhoefer L, Chaudhuri KR, Kamm C, Martinez-Martin P, Bhatia K, Sauerbier A, Kaiser M, Rodriguez-Blazquez C, Balint B, Untucht R, Hall LJ, Mildenstein L, Wienecke M, Martino D, Gregor O, Storch A, Reichmann H.

Ann Clin Transl Neurol. 2019 Oct;6(10):2054-2065. doi: 10.1002/acn3.50900. Epub 2019 Sep 27.

16.

Restless legs syndrome - the under-recognised non-motor burden: a questionnaire-based cohort study.

Sauerbier A, Sivakumar C, Klingelhoefer L, Martinez-Martin P, Perkins L, Inniss R, Rizos A, Trivedi D, Leta V, Wan YM, Parry M, van Wamelen D, Reichmann H, Chaudhuri KR.

Postgrad Med. 2019 Sep;131(7):473-478. doi: 10.1080/00325481.2019.1658506. Epub 2019 Sep 15.

PMID:
31522582
17.

Contractile dysfunction and nitrergic dysregulation in small intestine of a primate model of Parkinson's disease.

Coletto E, Dolan JS, Pritchard S, Gant A, Hikima A, Jackson MJ, Benham CD, Chaudhuri KR, Rose S, Jenner P, Iravani MM.

NPJ Parkinsons Dis. 2019 Jun 10;5:10. doi: 10.1038/s41531-019-0081-9. eCollection 2019.

18.

Barriers to reporting non-motor symptoms to health-care providers in people with Parkinson's.

Hurt CS, Rixon L, Chaudhuri KR, Moss-Morris R, Samuel M, Brown RG.

Parkinsonism Relat Disord. 2019 Jul;64:220-225. doi: 10.1016/j.parkreldis.2019.04.014. Epub 2019 Apr 20.

PMID:
31036430
19.

Should there be less emphasis on levodopa-induced dyskinesia in Parkinson's disease?

Chaudhuri KR, Jenner P, Antonini A.

Mov Disord. 2019 Jun;34(6):816-819. doi: 10.1002/mds.27691. Epub 2019 Apr 14. No abstract available.

PMID:
30983023
20.

Pilot Study of the International Parkinson and Movement Disorder Society-sponsored Non-motor Rating Scale (MDS-NMS).

Martinez-Martin P, Schrag A, Weintraub D, Rizos A, Rodriguez-Blazquez C, Chaudhuri KR; IPMDS Non Motor PD Study Group.

Mov Disord Clin Pract. 2019 Feb 5;6(3):227-234. doi: 10.1002/mdc3.12728. eCollection 2019 Mar.

21.

Slave to the rhythm: Seasonal differences in non-motor symptoms in Parkinson's disease.

van Wamelen DJ, Podlewska AM, Leta V, Śmiłowska K, Rizos A, Martinez-Martin P, Bloem BR, Chaudhuri KR.

Parkinsonism Relat Disord. 2019 Jun;63:73-76. doi: 10.1016/j.parkreldis.2019.02.041. Epub 2019 Feb 28.

PMID:
30867088
22.

Relationship of Nocturnal Sleep Dysfunction and Pain Subtypes in Parkinson's Disease.

Martinez-Martin P, Rizos AM, Wetmore JB, Antonini A, Odin P, Pal S, Sophia R, Carroll C, Martino D, Falup-Pecurariu C, Kessel B, Andrews T, Paviour D, Trenkwalder C, Chaudhuri KR; EUROPAR & MDS Non‐Motor PD Study Group.

Mov Disord Clin Pract. 2018 Nov 8;6(1):57-64. doi: 10.1002/mdc3.12694. eCollection 2019 Jan.

23.

Dietary Variations in a Multiethnic Parkinson's Disease Cohort and Possible Influences on Nonmotor Aspects: A Cross-Sectional Multicentre Study.

Sauerbier A, Schrag A, Martinez-Martin P, Hall LJ, Parry M, Mischley LK, Zis P, Chaudhuri KR.

Parkinsons Dis. 2018 Dec 18;2018:7274085. doi: 10.1155/2018/7274085. eCollection 2018.

24.

Continuous Drug Delivery Aiming Continuous Dopaminergic Stimulation in Parkinson's Disease.

van Wamelen DJ, Grigoriou S, Chaudhuri KR, Odin P.

J Parkinsons Dis. 2018;8(s1):S65-S72. doi: 10.3233/JPD-181476. Review.

25.

Levodopa-carbidopa intestinal gel in a subgroup of patients with dyskinesia at baseline from the GLORIA Registry.

Poewe W, Chaudhuri KR, Bergmann L, Antonini A.

Neurodegener Dis Manag. 2019 Feb;9(1):39-46. doi: 10.2217/nmt-2018-0034. Epub 2018 Dec 14.

26.

Management Recommendations on Sleep Disturbance of Patients with Parkinson's Disease.

Liu CF, Wang T, Zhan SQ, Geng DQ, Wang J, Liu J, Shang HF, Wang LJ, Chan P, Chen HB, Chen SD, Wang YP, Zhao ZX, Chaudhuri KR.

Chin Med J (Engl). 2018 Dec 20;131(24):2976-2985. doi: 10.4103/0366-6999.247210. No abstract available.

27.

Evaluation of nocturnal hypokinesia in Parkinson's disease using a novel patient/proxy questionnaire and correlations with objective monitoring.

Bhidayasiri R, Phokaewvarangkul O, Sringean J, Martinez-Martin P, Anan C, Kantachadvanich N, Chaudhuri KR, Hattori N.

Parkinsonism Relat Disord. 2019 Apr;61:219-223. doi: 10.1016/j.parkreldis.2018.09.023. Epub 2018 Sep 21.

PMID:
30314847
28.

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial.

Katzenschlager R, Poewe W, Rascol O, Trenkwalder C, Deuschl G, Chaudhuri KR, Henriksen T, van Laar T, Spivey K, Vel S, Staines H, Lees A.

Lancet Neurol. 2018 Sep;17(9):749-759. doi: 10.1016/S1474-4422(18)30239-4. Epub 2018 Jul 25.

PMID:
30055903
29.

Assessment and Management of Neuropsychiatric Symptoms in Parkinson's Disease.

Mueller C, Rajkumar AP, Wan YM, Velayudhan L, Ffytche D, Chaudhuri KR, Aarsland D.

CNS Drugs. 2018 Jul;32(7):621-635. doi: 10.1007/s40263-018-0540-6. Review.

PMID:
30027401
30.

Noninvasive options for 'wearing-off' in Parkinson's disease: a clinical consensus from a panel of UK Parkinson's disease specialists.

Fackrell R, Carroll CB, Grosset DG, Mohamed B, Reddy P, Parry M, Chaudhuri KR, Foltynie T.

Neurodegener Dis Manag. 2018 Oct;8(5):349-360. doi: 10.2217/nmt-2018-0020. Epub 2018 Jul 5.

31.

A noninterventional study evaluating the effectiveness of rotigotine and levodopa combination therapy in younger versus older patients with Parkinson's disease.

Woitalla D, Dunac A, Safavi A, Ceravolo MG, Gomez Esteban JC, Pavese N, Asgharnejad M, Joeres L, Schuller JC, Chaudhuri KR.

Expert Opin Pharmacother. 2018 Jun;19(9):937-945. doi: 10.1080/14656566.2018.1480721. Epub 2018 Jun 19.

PMID:
29916262
32.

A detailed clinical study of pain in 1957 participants with early/moderate Parkinson's disease.

Silverdale MA, Kobylecki C, Kass-Iliyya L, Martinez-Martin P, Lawton M, Cotterill S, Chaudhuri KR, Morris H, Baig F, Williams N, Hubbard L, Hu MT, Grosset DG; UK Parkinson's Pain Study Collaboration.

Parkinsonism Relat Disord. 2018 Nov;56:27-32. doi: 10.1016/j.parkreldis.2018.06.001. Epub 2018 Jun 6.

33.

Exploring Bedroom Usability and Accessibility in Parkinson's Disease (PD): The Utility of a PD Home Safety Questionnaire and Implications for Adaptations.

Bhidayasiri R, Jitkritsadakul O, Sringean J, Jantanapornchai T, Kantachadvanich N, Phumphid S, Boonpang K, Pensook S, Aungkab N, Hattori N, Chaudhuri KR.

Front Neurol. 2018 May 17;9:360. doi: 10.3389/fneur.2018.00360. eCollection 2018.

34.

Changes in Parkinson's disease sleep symptoms and daytime somnolence after bilateral subthalamic deep brain stimulation in Parkinson's disease.

Kharkar S, Ellenbogen JR, Samuel M, Rizos A, Silverdale M, Chaudhuri KR, Ashkan K.

NPJ Parkinsons Dis. 2018 May 25;4:16. doi: 10.1038/s41531-018-0053-5. eCollection 2018.

35.

Serotonergic dysregulation is linked to sleep problems in Parkinson's disease.

Wilson H, Giordano B, Turkheimer FE, Chaudhuri KR, Politis M.

Neuroimage Clin. 2018 Mar 2;18:630-637. doi: 10.1016/j.nicl.2018.03.001. eCollection 2018.

36.

First comprehensive tool for screening pain in Parkinson's disease: the King's Parkinson's Disease Pain Questionnaire.

Martinez-Martin P, Rizos AM, Wetmore J, Antonini A, Odin P, Pal S, Sophia R, Carroll C, Martino D, Falup-Pecurariu C, Kessel B, Andrews T, Paviour D, Trenkwalder C, Chaudhuri KR; EUROPAR and MDS Non-motor PD Study Group.

Eur J Neurol. 2018 Oct;25(10):1255-1261. doi: 10.1111/ene.13691. Epub 2018 Jun 22.

PMID:
29806962
37.

Non-motor Parkinson disease: new concepts and personalised management.

Titova N, Chaudhuri KR.

Med J Aust. 2018 May 21;208(9):404-409. Review.

PMID:
29764353
38.

Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson's disease.

Odin P, Chaudhuri KR, Volkmann J, Antonini A, Storch A, Dietrichs E, Pirtošek Z, Henriksen T, Horne M, Devos D, Bergquist F.

NPJ Parkinsons Dis. 2018 May 10;4:14. doi: 10.1038/s41531-018-0051-7. eCollection 2018. Review.

39.

Pain in Parkinson's disease: facts and uncertainties.

Antonini A, Tinazzi M, Abbruzzese G, Berardelli A, Chaudhuri KR, Defazio G, Ferreira J, Martinez-Martin P, Trenkwalder C, Rascol O.

Eur J Neurol. 2018 Jul;25(7):917-e69. doi: 10.1111/ene.13624. Epub 2018 Apr 18. Review.

PMID:
29520899
40.

Non motor symptoms in progressive supranuclear palsy: prevalence and severity.

Radicati FG, Martinez Martin P, Fossati C, Chaudhuri KR, Torti M, Rodriguez Blazquez C, Vacca L, Stocchi F.

NPJ Parkinsons Dis. 2017 Dec 8;3:35. doi: 10.1038/s41531-017-0037-x. eCollection 2017.

41.

The Parkinson's Disease Composite Scale: results of the first validation study.

Stocchi F, Radicati FG, Chaudhuri KR, Johansson A, Padmakumar C, Falup-Pecurariu C, Martinez-Martin P.

Eur J Neurol. 2018 Mar;25(3):503-511. doi: 10.1111/ene.13529. Epub 2018 Jan 13.

PMID:
29193455
42.

Erratum: Author Correction: Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson's disease.

Lakshminarayana R, Wang D, Burn D, Chaudhuri KR, Galtrey C, Guzman NV, Hellman B, James B, Pal S, Stamford J, Steiger M, Stott RW, Teo J, Barker RA, Wang E, Bloem BR, van der Eijk M, Rochester L, Williams A.

NPJ Parkinsons Dis. 2017 Nov 13;3:32. doi: 10.1038/s41531-017-0034-0. eCollection 2017.

43.

Advanced Parkinson's or "complex phase" Parkinson's disease? Re-evaluation is needed.

Titova N, Martinez-Martin P, Katunina E, Chaudhuri KR.

J Neural Transm (Vienna). 2017 Dec;124(12):1529-1537. doi: 10.1007/s00702-017-1799-3. Epub 2017 Nov 7. Review.

44.

Management of Psychosis in Parkinson's Disease: Emphasizing Clinical Subtypes and Pathophysiological Mechanisms of the Condition.

Taddei RN, Cankaya S, Dhaliwal S, Chaudhuri KR.

Parkinsons Dis. 2017;2017:3256542. doi: 10.1155/2017/3256542. Epub 2017 Sep 12. Review.

45.

Constipation is not associated with dopamine transporter pathology in early drug-naïve patients with Parkinson's disease.

Pagano G, Yousaf T, Wilson H, Niccolini F, Polychronis S, Chaudhuri KR, Politis M.

Eur J Neurol. 2018 Feb;25(2):307-312. doi: 10.1111/ene.13503. Epub 2017 Dec 11.

PMID:
29078029
46.

Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry.

Antonini A, Poewe W, Chaudhuri KR, Jech R, Pickut B, Pirtošek Z, Szasz J, Valldeoriola F, Winkler C, Bergmann L, Yegin A, Onuk K, Barch D, Odin P; GLORIA study co-investigators.

Parkinsonism Relat Disord. 2017 Dec;45:13-20. doi: 10.1016/j.parkreldis.2017.09.018. Epub 2017 Sep 22.

47.

Parkinson's Disease Subtypes Identified from Cluster Analysis of Motor and Non-motor Symptoms.

Mu J, Chaudhuri KR, Bielza C, de Pedro-Cuesta J, Larrañaga P, Martinez-Martin P.

Front Aging Neurosci. 2017 Sep 20;9:301. doi: 10.3389/fnagi.2017.00301. eCollection 2017.

48.

The cost-effectiveness of levodopa/carbidopa intestinal gel compared to standard care in advanced Parkinson's disease.

Lowin J, Sail K, Baj R, Jalundhwala YJ, Marshall TS, Konwea H, Chaudhuri KR.

J Med Econ. 2017 Nov;20(11):1207-1215. doi: 10.1080/13696998.2017.1379411. Epub 2017 Sep 21.

PMID:
28895769
49.

Rotigotine transdermal patch and sleep in Parkinson's disease: where are we now?

Rosa-Grilo M, Qamar MA, Taddei RN, Pagonabarraga J, Kulisevsky J, Sauerbier A, Chaudhuri KR.

NPJ Parkinsons Dis. 2017 Sep 5;3:28. doi: 10.1038/s41531-017-0030-4. eCollection 2017. Review.

50.

Identifying barriers to help-seeking for non-motor symptoms in people with Parkinson's disease.

Hurt CS, Rixon L, Chaudhuri KR, Moss-Morris R, Samuel M, Brown RG.

J Health Psychol. 2019 Apr;24(5):561-571. doi: 10.1177/1359105316683239. Epub 2016 Dec 1.

PMID:
28810364

Supplemental Content

Loading ...
Support Center